UK metered dose inhaler market is anticipated to grow at a substantial rate of around 2.5% during the forecast period. The metered dose inhalers find a significant role to treat respiratory diseases including asthma, bronchitis, emphysema, and COPD. As the prevalence of asthma and other respiratory diseases increases across UK, the demand for metered dose inhaler is also expected to increase for treatment purposes. As per the International Monetary Fund GDP of the country was $2.9 trillion in 2017. UK comprises England, Scotland, Wales and Northern Ireland. The total population of the country in 2017 was 65 million, out of which about 18% are of the geriatric population. Mortalities related to asthma and COPD are high in UK and due to these a significant investment by the government and people can be forecast in the near future.

A full report of UK Metered Dose Inhaler Market is available at: https://www.omrglobal.com/industry-reports/uk-metered-dose-inhaler-market

UK metered dose inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators metered dose inhaler are analyzed. The preventive inhaler segment led the global metered dose inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone.
Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/uk-metered-dose-inhaler-market

Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing metered dose inhalers to cater to a wide range of customers within the region and across the globe. The major players of the UK Metered Dose Inhaler market include Boehringer Ingelheim International GmbH, AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, Teva Pharmaceuticals Industries Ltd., Koninklijke Philips N.V., and Bespak. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players.

UK Metered Dose Inhaler Market- Segmentation

By Type

• Preventive Inhaler
• Reliever Inhaler
• Long Acting Bronchodilators Inhaler

By Application

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)

By End-User

• Homecare
• Hospitals and Clinics

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/uk-metered-dose-inhaler-market

Company Profiles

• 3M Co.
• Acorda Therapeutics, Inc.
• Adamis Pharmaceuticals Corp.
• Adherium Ltd.
• AstraZeneca PLC
• Bespak
• Boehringer Ingelheim International GmbH
• Chiesi Farmaceutici S.P.A.
• GF Health
• GlaxoSmithKline PLC
• H&T Presspart Manufacturing Ltd.
• Koninklijke Philips N.V.
• Novartis AG
• Omron Healthcare Inc.
• ResMed Corp.
• Pulmatrix Inc.
• Savara, Inc.
• Teicos Pharma Ltd.
• Teva Pharmaceuticals Industries Ltd.
• Vitalograph Ltd.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404